Originally Posted by
Fr8Master
If we can’t hammer down scope can we at least get an automatic flow agreement to ASL?
In all seriousness, the company stated the CGN FDA costs have increased to a level that is no longer sustainable? The exchange rate between the Euro and the Dollar is roughly 30% better TODAY than when they opened the domicile so I don’t buy that statement. Just six months ago they were plugging new hires into CGN….apparently in the last six months it just got way too expensive…..
It got way too expensive compared to subcontracting out 737s. It’s pretty obvious what’s going on, the new BOD and McKinsey are squeezing out every drop and the gaping hole in our scope clause was the first place they went.